Temozolomide in the management of dopamine agonist-resistant prolactinomas.
Whitelaw BC, Dworakowska D, Thomas NW, Barazi S, Riordan-Eva P, King AP, Hampton T, Landau DB, Lipscomb D, Buchanan CR, Gilbert JA, Aylwin SJ.
Whitelaw BC, et al.
Clin Endocrinol (Oxf). 2012 Jun;76(6):877-86. doi: 10.1111/j.1365-2265.2012.04373.x.
Clin Endocrinol (Oxf). 2012.
PMID: 22372583
Review.